“…It was assumed 167,169 that the biochemical decomposition of 125 and 126 would lead to a very reactive bioalkylating species 129 which could cross-link the DNA, whereas 123 and 124 would decompose to a much less reactive monoalkylating species 130 (Chart 4). The two cytotoxic metabolites, the sulfoxide, perimustine (125), and the sulfone, cystemustine (126), were compared 169 with CNCC against 12 cancer models in vivo. Both compounds were found 169 to be at least as active as CNCC against eight of the leukemia lymphomas and solid cancers, but, more importantly, the two metabolites caused a larger percentage of long-term survivors on day 90 than the parent mixture CNCC.…”